Critical Residues on HLA-DRB1*0402 HV3 Peptide for HLA-DQ8-Restricted Immunogenicity: Implications for Rheumatoid Arthritis Predisposition

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3545-3551

  Zanelli, Eric ^a,b   Krco, Christopher J ^a   David, Chella S ^a,c  

^a MAYO CLINIC   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; DISEASE PREDISPOSITION; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; DISEASE SUSCEPTIBILITY; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; IMMUNODOMINANT EPITOPES; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 0031112358     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Winchester, R., E. Dwyer, and S. Rose, 1992. The genetic basis of rheumatoid arthritis: the shared epitope hypothesis. Rheum. Dis. Clin. North Am. 18:761.
2. Albani, S., and J. Roudier. 1992. Molecular basis for the association between HLA DR4 and rheumatoid arthritis. From the shared epitope hypothesis to a peptidic model of rheumatoid arthritis. Clin. Biochem. 25:209.
3. Roudier, J., J. Petersen, G. H. Rhodes, J. Lukas, and D. A. Carson. 1989. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DRβ1 chain and the Epstein-Barr virus glycoprotein gp110. Proc. Natl. Acad. Sci. USA 86:5104.
4. Salvat, S., I. Auger, L. Rochelle, A. Begovich, L. Geburher, A. Sette, and J. Roudier. 1994. Tolerance to a self-peptide from the third hypervariable region of HLA-DRB1*0401 in rheumatoid arthritis patients and normal subjects. J. Immunol. 153:5321.
5. Gonzalez-Gay, M. A., G. H. Nabozny, M. J. Bull, E. Zanelli, J. Douhan III, M. M. Griffiths, L. H. Glimcher, H. S. Luthra, and C. S. David. 1994. Protective role of major histocompatibility class II Ebd transgene on collagen-induced arthritis. J. Exp. Med. 180:1559.
6. Gonzalez-Gay, M. A., E. Zanelli, C. J. Krco, G. H. Nabozny, J. Hanson J, M. M. Griffiths, H. S. Luthra, and C. S. David. 1995. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics 42:35.
7. Zanelli, E., C. J. Krco, J. M. Baisch, S. Cheng, and C. S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arrthritis. Proc. Natl. Acad. Sci. USA 93:1814.
8. Zanelli, E., M. A. Gonzalez-Gay, and C. S. David. 1995. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today 16:274.
9. Nabozny, G. H., J. M. Baisch, S. Cheng, D. Cosgrove, M. M. Griffiths, H. S. Luthra, and C. S. David. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:27.
10. Doherty, D. G., R. W. Vaughan, P. T. Donalson, and A. P. Mowat. 1992. HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids. Hum. Immunol. 34:53.
11. Maeda, H., T. Juji, H. Mitsui, H. Sonozaki, and K. Okitsu. 1981. HLA DR4 and rheumatoid arthritis in Japanese people. Ann. Rheum. Dis. 40:299.
12. Gonzalez, A., S. Nicovani, L. Massardo, P. Bull, L. Rodriguez, and S. Jacobelli. 1992. Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum. 35:282.
13. De Juan, M. D., I. Belmonte, J. Barado, J. Martinez Laso, M. Figueroa, A. Amaiz-Villena, and E. Cuadrado. 1994. Differential associations of HLA-DR antigens with rheumatoid arthritis (RA) in Basques: high frequency of DR1 and DR10 and lack of association with HLA-DR4 or any of its subtypes. Tissue Antigens 43:320.
14. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
15. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
16. Agrawal, S., A. Aggarwal, S. Dabadghao, S. Naik, and R. Misra. 1995. Compound heterozygosity of HLA-DR4 and DR1 antigens in Asian Indians increases the risk of extra-articular features in rheumatoid arthritis. Br. J. Rheumatol. 34: 41.
17. Ploski, R., O. J. Mellbye, K. S. Rønningen, O. Førre, and E. Thorsby. 1994. Seronegative and weakly seropositive rheumatoid arthritis differ from clearly seropositive rheumatoid arthritis in HLA class II associations. J. Rheumatol. 21: 1397.
18. Krco, C. J., T. G. Beito, and C. S. David. 1992. Determination of tolerance to self Eα peptides by clonal elimination of H-2E reactive T cells and antigen presentation by H-2A molecules. Transplantation 54:920.
19. Chicz, R. M., W. S. Lanes, R. A. Robinson, M. Trucco, J. L. Strominger, and J. C. Gorga. 1994. Self-peptides bound to the type I diabetes-associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int. Immunol. 6:1639.
20. Kvien, T. K., A. Glennas, K. Melby, K. Grantors, O. Andrup, B. Karstensen, and J. E. Thoen. 1994. Reactive arthritis: incidence, triggering agents and clinical presentation. J. Rheumatol. 21:115.
21. Coll, J. L., A. Ben-Ze'ev, R. M. Ezzell, J. L. Rodriguez Fernandez, H. Baribault, R. G. Oshima, and E. D. Adamson. 1995. Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion. Proc. Natl. Acad. Sci. USA 92:9161.
22. Kwok, W. W., M. A. Domeier, F. C. Raymond, P. Byers, and G. T. Nepom. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171.
23. Khalil, I., L. d'Auriol, M. Gobet, L. Morin, V. Lepage, I. Deschamps, M. S. Park, L. Degos, F. Galibert, and J. Hors. 1990. A combination of HLA-DQβ Asp57-negative and HLA-DQα Arg 52 confers susceptibility to insulin-dependent diabetes mellitus. J. Clin. Invest. 85:1315.
24. Huang, H. S, J. T. Peng, J. Y. She, L. P. Zhang, C. C. K. Chao, K. H. Liu, and J. X. She. 1995. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum. Immunol. 44:210.
25. Luo, A. M., K, M. Garza, D. Hunt, and K. S. Tung. 1993. Antigen mimicry in autoimmune disease by sharing of amino acid residues critical for pathogenic T cell activation. J. Clin. Invest. 92:2117.
26. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T-cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
27. Bhardwaj, V., V. Kumar, H. M. Geysen, and E. E. Sercarz. 1993. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J. Immunol. 151: 5000.
28. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.
29. Kisielow, P., H. S. The, H. Blüthmann, and H. Von Boehmer. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335:730.